drugset / Trial / NCT00004397
Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria
Phase 1
Completed
20 enrolled
National Center for Research Resources (NCRR)
University of Texas · collab
Treatment
Summary
OBJECTIVES: I. Evaluate the effectiveness of tin mesoporphyrin in reducing the number of heme infusions needed to prevent acute attacks of porphyria. II. Evaluate the safety and tolerability of tin mesoporphyrin in these patients.
Timeline
- Start
- 1998-01
- Primary completion
- —
- Completion
- 2000-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | stannsoporfin | Small molecule | — | — |
| Background | heme arginate | Small molecule | — | — |